NCT03435978 is a clinical trial of MetS+ in Obesity, Metabolically Benign, sponsored by Louis Turcanu Emergency Hospital for Children.

Who is sponsoring NCT03435978?

NCT03435978 is sponsored by Louis Turcanu Emergency Hospital for Children.

What drugs are being tested in NCT03435978?

Interventions in NCT03435978: MetS+, MetS-.

What condition does NCT03435978 study?

NCT03435978 studies Obesity, Metabolically Benign.

Is NCT03435978 still recruiting?

NCT03435978 is currently completed. Last updated 19 February 2018.

Last reviewed 2018-02-19 · How we verify

NCT03435978

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Diet and Physical Activity on Adipokines

Completed Last updated 19 February 2018

What this trial tests

trial testing MetS+ in Obesity, Metabolically Benign in 66 participants. Completed in 3 January 2018.

Timeline

1 January 2016

Primary endpoint
31 December 2016

3 January 2018

Quick facts

Lead sponsor	Louis Turcanu Emergency Hospital for Children
Status	Completed
Study type	OBSERVATIONAL
Enrollment	66
Start date	1 January 2016
Primary completion	31 December 2016
Estimated completion	3 January 2018

Drugs / interventions tested

MetS+
MetS-

Conditions studied

Obesity, Metabolically Benign — all drugs for Obesity, Metabolically Benign →

Sponsor

Louis Turcanu Emergency Hospital for Children

Who can join

Adults 5 to 18, any sex, with Obesity, Metabolically Benign. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The prevalence of metabolic syndrome (MetS) in young population continues to rise. Obesity is a chronic inflammatory disorder in which leptin, adiponectin and C reactive protein (CRP) play an important role. This study aimed to determine whether these adipokines are significant markers in defining MetS in pediatric population and to assess the effect of hypocaloric diet and physical activity on serum concentrations of adiponectine, leptin, and high sensitivity CRP (hs-CRP).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of MetS+

Trials testing the same drug.

NCT03354676 — Adiponectin, Leptin, h-CRP Values in Obese Children - Important Markers for Metabolic Syndrome? · completed

Other recruiting trials for Obesity, Metabolically Benign

Currently open trials in the same condition.

NCT05933707 — Small Extracellular Vesicles and Insulin Action · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03435978 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Louis Turcanu Emergency Hospital for Children
Last refreshed: 19 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03435978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing